Norepinephrine Bitartrate
重酒石酸去甲肾上腺素
Report date: 2026/01/29 16:59:47
NME
Base Information
Drug NameNorepinephrine Bitartrate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[14]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1950/07/13
Country/Territory +[10]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHospira
China Registration ClassN/A
Develop Information
Active CompaniesAarhus UniversityThe University Of EdinburghJagiellonian University Sylff Fellows Association +[12]
Inactive CompaniesMansoura UniversityUniversity Of LouisvilleNational Institute Of Neurological Disorders And Stroke +[5]
Active Indications +[8]
Inactive Indications +[6]